T80.810D is the ICD 10 code for Extravasation of vesicant antineoplastic chemotherapy, subsequent encounter

T80.810D ICD 10 Code is a billable and specific code that can be used to indicate a diagnosis of Extravasation of vesicant antineoplastic chemotherapy, subsequent encounter for reimbursement purposes. The 2023 edition of the American ICD-10-CM code became effective on October 1, 2022.

Short description for T80.810D ICD 10 code:

Extravasation of vesicant antineoplastic chemotherapy, subs

Present On Admission (POA Exempt)

T80.810D ICD 10 code is considered exempt from POA reporting